Thiocarboxamide derivatives
Abstract
Compounds of formula (1): wherein: R 1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic; polyheterocycloaliphatic, aromatic, or heteroaromatic group; Alk 1 is an optionally substituted aliphatic or heteroaliphatic chain; L 1 is a linker atom or group; r and s is each zero or an integer 1; R 2 and R 3 , which may be the same or different, is each a hydrogen or halogen atom or a straight or branched alkyl, haloalkyl, alkoxy, haloalkoxy, hydroxyl or nitro group; Alk 2 is a straight or branched alkylene chain; is zero or an integer 1; R 4 is a hydrogen atom or a methyl group; R 5 is a hydrogen atom or a straight or branched alkyl group; R 6 is a group —(CH 2 ) t R 7 in which t is zero or the integer 1 and R 7 is an optionally substituted polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group; R is a carboxylic acid (—CO 2 H) or a derivative thereof; and the salts, solvates and hydrates thereof are described The compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
Claims
exact text as granted — not AI-modified1 . A compound of formula (1):
wherein
R 1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group;
Alk 1 is an optionally substituted aliphatic or heteroaliphatic chain;
L 1 is a linker atom or group;
r and s is each zero or an integer 1;
R 2 and R 3 , which may be the same or different, is each a hydrogen or halogen atom or a straight or branched alkyl, haloalkyl, alkoxy, haloalkoxy, hydroxyl or nitro group;
Alk 2 is a straight or branched alkylene chain;
m; is zero or an integer 1;
R 4 is a hydrogen atom or a methyl group;
R 5 is a hydrogen atom or a straight or branched alkyl group;
R 6 is a group —(CH 2 ) t R 7 in which t is zero or the integer 1 and R 7 is an optionally substituted polycycloaliphatic, heterocycloaliphatic, polyhetero-cycloaliphatic, aromatic or heteroaromatic group;
R is a carboxylic acid (—CO 2 H) or a derivative thereof;
and the salts, solvates and hydrates thereof.
2 . A compound according to claim 1 wherein R is a —CO 2 H group.
3 . A compound according to claim 1 wherein Alk is a —CH 2 — chain and m is an integer 1.
4 . A compound according to claim 1 wherein R 4 and R 5 is each a hydrogen atom.
5 . A compound according to claim 1 wherein -Alk 1 L 1 - is a —CH 2 O— or —CON(R 8 )— group where R 8 is a hydrogen atom or a straight or branched alkyl group.
6 . A compound according to claim 1 wherein R 1 is an optionally substituted aromatic or heteroaromatic group.
7 . A compound according to claim 6 wherein R 1 is an optionally substituted phenyl, pyridyl or pyrimidinyl group.
8 . A compound according to claim 1 wherein R 6 is an optionally substituted heterocycloaliphatic, romatic or heteroaromatic group.
9 . A compound according to claims 8 wherein R 6 is an optionally substituted pyrrolidinyl, thiazolidinyl, phenyl or pyridyl group.
10 . A pharmaceutical composition comprising a compound of formula (1):
wherein
R 1 is a hydrogen atom or an optionally substituted cycloaliphatic, polycycloaliphatic, heterocycloaliphatic, polyheterocycloaliphatic, aromatic or heteroaromatic group;
Alk 1 is an optionally substituted aliphatic or heteroaliphatic chain;
L 1 is a linker atom or group,
r and s is each zero or an integer 1;
R 2 and R 3 , which may be the same or different, is each a hydrogen or halogen atom or a straight or branched alkyl, haloalkyl, alkoxy, haloalkoxy, hydroxyl or nitro group;
Alk 2 is a straight or branched alkylene chain;
m is zero or an integer 1;
R 4 is a hydrogen atom or a methyl group;
R 5 is a hydrogen atom or a straight or branched alkyl group;
R 6 is a group —(CH 2 ) t R 7 in which t is zero or the integer 1 and R 7 is an optionally substituted polycycloaliphatic, heterocycloaliphatic, polyhetero-cycloaliphatic, aromatic or heteroaromatic group;
R is a carboxylic acid (—CO 2 H) or a derivative thereof;
and the salts, solvates and hydrates thereof; together with one or more pharmaceutically acceptable carriers, excipients or diluents.Join the waitlist — get patent alerts
Track US2003119853A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.